Trial Profile
Temozolomide in the management of anaplastic astrocytoma
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 17 Jul 2015
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary) ; Antineoplastics
- Indications Anaplastic astrocytoma
- Focus Therapeutic Use
- 17 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.